TipRanks
Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF
US Market

Santhera Pharmaceuticals Holding (SPHDF) Stock Forecast & Price Target

40 Followers
See the Price Targets and Ratings of:

SPHDF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Santhera
Pharmaceuticals Holding
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SPHDF Stock 12 Month Forecast

There Are No Analyst Ratings for SPHDF In The Last 3 Months.
Highest Price Target―Average Price Target―Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SPHDF Financial Forecast

SPHDF Earnings Forecast

The previous quarter’s earnings for SPHDF were -$0.11.
The previous quarter’s earnings for SPHDF were -$0.11.

SPHDF Sales Forecast

The previous quarter’s earnings for SPHDF were $57.78M.
The previous quarter’s earnings for SPHDF were $57.78M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SPHDF
H.C. Wainwright
H.C. Wainwright
$35.87
Buy
51.21%
Upside
Reiterated
07/02/26
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL) and Santhera Pharmaceuticals Holding (Other OTC: SPHDF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on SPHDF
H.C. Wainwright
H.C. Wainwright
$35.87
Buy
51.21%
Upside
Reiterated
07/02/26
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL) and Santhera Pharmaceuticals Holding (Other OTC: SPHDF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
KURAKura Oncology
DNLIDenali Therapeutics
OVIDOvid Therapeutics
HITIHigh Tide
AXGNAxoGen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Santhera Pharmaceuticals Holding

3 Months
Ram SelvarajuH.C. Wainwright
Success Rate
4/8 ratings generated profit
50%
Average Return
+8.77%
Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +8.77% per trade.
1 Year
Ram SelvarajuH.C. Wainwright
Success Rate
5/8 ratings generated profit
63%
Average Return
+24.55%
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +24.55% per trade.
2 Years
Ram SelvarajuH.C. Wainwright
Success Rate
5/8 ratings generated profit
63%
Average Return
+18.65%
Copying Ram Selvaraju's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +18.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SPHDF Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
2
2
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
2
2
1
0
In the current month, SPHDF has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SPHDF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

SPHDF Stock Forecast FAQ

What is SPHDF’s average 12-month price target, according to analysts?
Currently, no data Available
What is SPHDF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SPHDF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SPHDF a Buy, Sell or Hold?
      Currently, no data Available
      What is Santhera Pharmaceuticals Holding’s price target?
      Currently, no data Available
      What do analysts say about Santhera Pharmaceuticals Holding?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SPHDF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.